Cargando…
Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors
More than fifteen million women with the human immunodeficiency virus type-1 (HIV-1) infection are of childbearing age world-wide. Due to improved and affordable access to antiretroviral therapy (ART), the number of in utero antiretroviral drug (ARV)-exposed children has exceeded a million and conti...
Autores principales: | Foster, Emma G., Palermo, Nicholas Y., Liu, Yutong, Edagwa, Benson, Gendelman, Howard E., Bade, Aditya N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988942/ https://www.ncbi.nlm.nih.gov/pubmed/36896351 http://dx.doi.org/10.3389/ftox.2023.1113032 |
Ejemplares similares
-
HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
por: Foster, Emma G., et al.
Publicado: (2022) -
Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment
por: Bade, Aditya N., et al.
Publicado: (2021) -
Integrase Strand Transfer Inhibitors in HIV Therapy
por: Mesplède, Thibault, et al.
Publicado: (2013) -
Multiple choices for HIV therapy with integrase strand transfer inhibitors
por: Raffi, Francois, et al.
Publicado: (2012) -
Structure-Guided
Optimization of HIV Integrase Strand
Transfer Inhibitors
por: Zhao, Xue Zhi, et al.
Publicado: (2017)